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Synthesis of oligodeoxynucleotides containing 2'-deoxyzebularine (dZ) 1 .1 General methods High-resolution electrospray mass spectra were recorded on a ThermoScientific Q Exactive Focus Hybrid Quadrupole-Orbitrap mass spectrometer. Ions generated by ESI were detected in negative ion mode. Total ion count (TIC) was recorded in centroid mode over the m/z range of 500-3,000 and analyzed using ThermoXcalibur Qual Browser. 'Saltless buffer' used for oligonucleotide desalting consists of 10 µM Tris-HCl (pH 8.0), 1 µM EDTA and 0.001% w/v NaN 3 .
1.2
Synthesis of dZ-modified oligos 2'-Deoxyzebularine phosphoramidite was prepared as described previously. 1 Oligonucleotide syntheses were carried out on a MerMade-4 DNA/RNA synthesizer (BioAutomation) on a 5 µmol scale using the manufacturer's standard protocol. Coupling time of 2'-deoxyzebularine phosphoramidite was increased to 5 min. The final detritylation step was omitted and DMT-ON oligonucleotides were cleaved from the solid support and deprotected with conc. ammonia solution (1.0 mL) at room temperature for 24 h. After filtering, an aq. solution of 0.3 M LiClO 4 (0.5 mL) was added and oligonucleotides were precipitated with acetone (14 mL). The DMT-ON oligonucleotides were isolated by reversedphase HPLC on 250/10 mm, 5 µm, 300 Å C18 column (Phenomenex) in a gradient of CH 3 CN (0→60% for 15 min, 4.6 mL/min) in 0.1 M TEAA buffer (pH 7.0) with detection at 260 nm.
DMT-ON oligonucleotides were freeze-dried and manually detritylated with 80% aq. AcOH (2 mL) during 20 min at room temperature. 3 M AcONa solution (0.5 mL) was then added and oligonucleotides were precipitated with 2-propanol (11 mL). DMT-OFF oligonucleotides were purified by RP-HPLC on 250/4.6 mm, 5 µm, 300 Å C18 column (Phenomenex) in a gradient of CH 3 CN (0→25% for 20 min, 1.3 mL/min) in 0.1 M TEAA buffer (pH 7.0) (Chart S1).
Fractions containing desired oligonucleotides were combined, freeze-dried, dissolved in milli-Q water (1.5 mL) and desalted on a NAP-25 column (GE Healthcare) against 'saltless buffer'. Pure products were quantified by measuring absorbance at 260 nm, analyzed by ESI-MS (Table SI) and concentrated by freeze-drying. TdZA-oligo was synthesized previously.
.
S3 Table S1 . Modified oligonucleotides and purified using protocols described above. Chart S1. Reverse-phase HPLC analytical profiles of purified CCdZ and dZCC oligos. S4 
Protein expression and purification
Proteins were prepared as described previously 1 (Chart S2). The A3B C-terminal domain (residues 187 to 378, UniProt ID Q9UH17 ) was cloned into pET24a vector (Novagen) to produce A3B CTD proteins with a non-cleavable C-terminal His 6 -tag (LEHHHHHH), adapted from a previously described study. 2 Derivative constructs previously reported were used in this study, A3B CTD -QM-∆L3-AL1swap (termed A3A-mimic), and A3B CTD -DM expressed in the E. coli strain C41(DE3)pLysS (Lucigen). E. coli culture was grown at 37 °C in LB medium. Once mid-log growth phase was established the culture was supplemented with 100 µM zinc chloride, before inducing protein expression by the addition of isopropyl β-D-1thiogalactopyranoside (IPTG) at a final concentration of 0.5 µM and incubating overnight at 18 °C.
GST-fused A3G CTD (191-384, NM_021822, wt) was purified as previously described. 3 The Nterminal glutathione S-transferase (GST)-fused A3G CTD was expressed in E. coli BL21(DE3) cells overnight at 17°C. After harvesting, the cells were resuspended in 50 mM sodium phosphate buffer (pH 7.4) and lysed by sonication. After ultracentrifugation at 25,000 g for 10 min, the supernatant was added to glutathione (GSH)-Sepharose, which was subsequently washed. For kinetic analysis, the GST fusion protein was eluted from the Sepharose matrix with 100 mM GSH in phosphate buffer. By using filtration at 4,000 g, the buffer was changed to a solution containing 75 mM sodium phosphate and 75 mM citrate, at pH 5.5. Kinetic characterization of A3 protein variants (A3B CTD -QM-∆L3-AL1swap, A3B CTD -DM, and A3G CTD ) on preferred dC in CCC-, dZCC-, CCdZ-oligos was made using an established NMRbased assay 3 (see Table S2 for description of oligos used). Measurements were acquired on a 700-MHz Bruker NMR spectrometer equipped with a 1.7-mm cryoprobe at 298 K. A series time of the reaction. The data were then fitted by linear regression to determine the initial speed of the reaction as a function of substrate concentration (Charts S8, S10, S12, S14, S16). The data as double reciprocal plots (Charts S9, S11, S13, S15 and S17) were then fitted with linear regression to determine K m and k cat (see explanation below). Uncertainties of K m and k cat were calculated using error-propagation method.
In ideal situation, it should be possible to obtain K m and k cat values by direct fitting of the substrate/initial rate data. For A3 enzymes, the analysis of product formation over long time is complicated by several factors: i) instability of enzymes during long experiments and ii) when substrate concentration decreases the enzyme starts to deaminate other cytosines in the CCdU-and dUCC-motifs. Using NMR assay the initial rate of deamination for the preferred cytosine (the one that is deaminated first) can be obtained. By performing experiments at different substrate concentrations, the data obtained that can be fitted with S9 a straight line in a double-reciprocal plot, which is much more meaningful to analyse than fitting into any other curve shape. For proper evaluation of K m and K i values, the use of the same but suboptimal pH, for example pH = 7 between optimal pH of A3A-mimic and A3Bctd, is not feasible in NMR assay:
reaction speed of A3A-mimic and A3Bctd is at least halved (Chart S4 in Supporting Information) and for A3Gctd is 10 times lower in comparison with reaction speed at optimal pH. 3 For A3Gctd, the enzyme cannot be saturated with the CCC-oligo (substrate) at pH 7 even at 10 mM substrate concentration. 3 This means that it is unfeasible not only to reliably detect enzyme activity on modified substrates and to measure residual enzyme activity in the presence of inhibitors but also to kinetically characterise substrates and inhibitors at pH = 7. One should note that for the wild-type enzymes the discrimination pattern for deamination of 5'-C versus 3'-C in the CCC-motif is prevalent in physiological pH around 7, 4 which means that our inhibitors would be still selective on wild-type enzymes at this pH. S10 Northwest TC125 temperature controller. CD spectra (average of at least 3 scans) were recorded between 220 and 350 nm with 1 nm intervals, 120 nm/min scan rate followed by subtraction of a background spectrum (buffer only). Stem-loop DNA structures usually have distinctive features of DNA duplexes with a peak at 280 nm with positive ellipticity and a S12 peak at 250 nm with negative ellipticity 5 (not observed here). We also did not see any distinctive patterns of other non-canonical DNA secondary structures 5 including an i-motif formed in C-rich regions. m-Fold cannot predict such structures. 
Evaluation of inhibitors in NMR-based assay
The NMR-based inhibition assay described previously 1, 3 was conducted to determine the deaminase activity of A3 variants in the presence of dZ-containing oligodeoxynucleotides. 1 H NMR spectra were recorded using 350 µM 5'-ATTTCATTT as a substrate for A3A-mimic and A3B CTD -DM with varying concentrations of dZ-oligos ranging from 5 µM to 100 µM in the presence of 50 nM of A3B CTD -QM-∆L3-AL1swap (A3A-mimic) or 2 µM of A3B CTD -DM in activity assay buffer as mentioned previously at 298 K.
Integration of the H-5 proton doublet signal of the cytosine (between 5.92 to 5.88 ppm, Chart S19) is converted to substrate concentration and plotted versus time of the reaction (Chart S20). This plot was then fitted with linear regression to determine the speed of the reaction in the presence of inhibitor. The Dixon plot of inverse speed versus inverse inhibitor concentration (Figures 3C and D in the main text) was then fitted with linear regression to derive the inhibition constant (K i ). Uncertainty of K i was calculated using error-propagation method.
Chart S19. 1 H NMR spectra of TCA-oligo in the presence of A3A-mimic in the absence (left) and presence of inhibitor (CCdZ-oligo, right) at different time intervals. 1 H NMR spectra of the substrate and the product are provided for reference. 
